Package Leaflet: Information for the User
Insuman Basal 40 UI/ml injectable suspension in a vial
Human insulin
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack and other information:
Insuman Basal contains human insulin as the active substance, which is produced by a biotechnology process and is identical to the insulin produced by the human body.
Insuman Basal is an insulin preparation with a gradual onset of action and a long duration of action.
The insulin is present in the form of small crystals of protamine insulin.
Insuman Basal is used to reduce high blood sugar levels in patients with diabetes mellitus who require insulin treatment. Diabetes mellitus is a disease in which the body does not produce enough insulin to control blood sugar levels.
Do not use Insuman Basal
If you are allergic to insulin or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use Insuman Basal.
Follow strictly the instructions regarding dosage, monitoring (blood and urine tests), diet, and physical activity (work and exercise) as agreed with your doctor.
Consult your doctor if you are allergic to this medicine or to human insulins.
Special patient groups
If you have liver or kidney problems or if you are elderly, consult your doctor, as you may need a lower dose of insulin.
Changes in the skin at the injection site
The injection site should be rotated to avoid changes in the skin, such as lumps under the skin. Insulin may not work as well if it is injected into a lump (see How to use Insuman Basal). Contact your doctor if you are currently injecting into a lump, before starting to inject into a different area. Your doctor may advise you to check your blood sugar levels more closely and adjust your insulin or other anti-diabetic medications.
Travel
Before traveling, consult your doctor. You may need to discuss:
Illnesses and injuries
The management of your diabetes may require special care in the following situations:
In most cases, you will need a doctor. Make sure to consult a doctor immediately.
If you have type 1 diabetes (insulin-dependent diabetes mellitus), do not stop taking your insulin and follow a diet with sufficient carbohydrates. Always inform the people taking care of you that you need insulin.
Some patients with type 2 diabetes mellitus of long duration and previous heart disease or stroke who were treated with pioglitazone and insulin developed heart failure. Inform your doctor as soon as possible if you experience symptoms of heart failure such as unusual shortness of breath or rapid weight gain or localized swelling (edema).
Other medicines and Insuman Basal
Some medicines can change your blood sugar levels (either increasing or decreasing them, depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are too high or too low. Be careful when starting to take another medicine and also when stopping one.
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Ask your doctor before using a medicine if it can affect your blood sugar level and what measures you should take, if necessary.
Among the medicines that can cause a decrease in your blood sugar level (hypoglycemia) are:
Among the medicines that can cause an increase in your blood sugar level (hyperglycemia) are:
Your blood sugar level may rise or fall if you use:
Pentamidine (used to treat some parasitic infections) can cause hypoglycemia, which may sometimes be followed by hyperglycemia.
Beta-blockers, like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine), can mask or completely suppress the early warning symptoms that could help you recognize hypoglycemia.
If you are not sure whether you are using any of these medicines, ask your doctor or pharmacist.
Insuman Basal with alcohol
Your blood sugar levels may rise or fall if you consume alcohol.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Tell your doctor if you are planning to have a baby or if you are already pregnant. Your insulin regimen may need to be changed during pregnancy and after delivery. Very careful control of your diabetes and prevention of hypoglycemia are important for the health of your baby. However, there is no experience with the use of Insuman Basal in pregnant women.
If you are breastfeeding, you may need to adjust your insulin dose and diet.
Driving and using machines
Your ability to concentrate or react may be reduced if
Be aware of this possible problem, considering all situations that may pose a risk to you or others (such as driving a vehicle or using machines). You should ask your doctor for advice on your ability to drive if:
Important information about some of the ingredients of Insuman Basal
This medicine contains less than 23 mg of sodium per dose; it is essentially "sodium-free".
Dose
Follow exactly the instructions for administration of this medicine given by your doctor or pharmacist. If you are not sure, consult your doctor or pharmacist again.
Based on your lifestyle and the results of your blood sugar (glucose) tests and your previous insulin treatment, your doctor will:
Many factors can influence your blood sugar level. You should know these factors so that you can react correctly to changes in your blood sugar level and avoid it becoming too high or too low. See the box at the end of this leaflet for more information.
Frequency of administration
Insuman Basal is injected under the skin 45 to 60 minutes before a meal.
Method of administration
Insuman Basal is a liquid (suspension) for injection under the skin.
Do not inject Insuman Basal into a vein (blood vessel).
Your doctor will show you which area of the skin to inject Insuman Basal into. With each injection, you should change the injection site within the area of skin you are using.
Do not use in insulin pumps or other infusion pumps. There are special insulin preparations for use in these devices.
How to handle the vials
Insuman Basal contains 40 UI of insulin per ml. Only syringes for injection designed for this concentration of insulin (40 UI per ml) should be used. The syringes for injection should not contain other medicines or residues of them (e.g., residues of heparin).
Before withdrawing the first dose of insulin, remove the removable protective cap from the vial.
Immediately before each injection, mix the insulin well. The best way to do this is to tilt the vial between the palms of your hands. Do not shake the vial vigorously, as this may cause foam to form. Foam can make it difficult to measure the correct dose.
After mixing, the suspension should have a uniform white, milky appearance. Do not use it if it remains transparent or if, for example, there are lumps, flakes, flocculation, or similar deposits in the suspension or on the walls or bottom of the vial. In such cases, use a new vial with a uniform suspension after mixing.
A new vial will also be used if you notice that your blood sugar control is unexpectedly worsening. This is because the insulin may have lost some of its effectiveness. If you think you may have a problem with your insulin, have it checked by your doctor or pharmacist.
Special precautions before injection
Before injection, remove all air bubbles. Make sure the insulin is not contaminated with alcohol or other disinfectants or with other substances. Do not mix insulin with any other medicine except for human insulin preparations as described below.
Insuman Basal can be mixed with all human insulin preparations, EXCEPT those designed specifically for insulin pumps. Similarly, it MUST NOT be mixed with insulins of animal origin or insulin analogs.
Your doctor will tell you if you need to mix human insulin preparations. If you need to inject a mixture, put Insuman Basal in the syringe first, before adding the other insulin. Inject immediately after mixing. Do not mix insulins of different concentrations (e.g., 100 UI/ml and 40 UI/ml).
If you use more Insuman Basal than you should
If you forget to use Insuman Basal
If you stop using Insuman Basal
This could lead to severe hyperglycemia (very high blood sugar levels) and ketoacidosis (increased acid in the blood because the body breaks down fat instead of sugar). Do not stop your treatment with Insuman Basal without consulting your doctor immediately, who will determine if you are truly allergic and advise you on what to do.
If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.
Insulin confusion
Always check the insulin label before each injection to avoid mix-ups between Insuman Basal and other insulins.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
More serious adverse effects
Adverse effects reported with low frequency(may affect up to 1 in 100 people)
Adverse effects reported with unknown frequency(frequency cannot be estimated from available data)
Other adverse effects
Adverse effects reported with frequency(may affect up to 1 in 10 people)
Insulin treatment may cause temporary water retention in the body with swelling of the calves and ankles
Adverse effects reported with low frequency
Other adverse effects reported with unknown frequency
A significant change (improvement or worsening) in the control of your blood sugar level can temporarily alter your vision. If you have proliferative retinopathy (an eye disease related to diabetes), severe hypoglycemic attacks can cause temporary loss of vision.
If insulin is injected too frequently in the same place, the fatty tissue can shrink (lipoatrophy) or become thicker (lipohypertrophy). Lumps under the skin can also occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis). Insulin may not work very well if injected into a lumpy area. Change the injection site to help avoid these skin changes.
Moderate allergic reactions may occur at the injection site (such as redness, pain, especially intense when injecting, itching, urticaria, swelling, or inflammation). These reactions can also spread around the injection site. Most mild reactions to insulins usually resolve on their own within a few days or weeks.
Insulin treatment may cause the body to produce antibodies against insulin (substances that act against insulin). However, this will only require modifying your insulin dose in rare cases.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the national reporting system included in Annex V.
By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging and on the label of the vial after "EXP". The expiration date is the last day of the month indicated.
Unopened vials
Store in a refrigerator (between 2°C and 8°C). Do not freeze. Do not place Insuman Basal near the freezer compartment or next to a cold accumulator.
Keep the vial in the outer packaging to protect it from light.
Opened vials
Once in use, the vial can be stored for a maximum of 4 weeks in the outer packaging at a temperature not exceeding 25°C and protected from direct heat (e.g., next to a heating unit) or direct light (direct sunlight or next to a lamp). Do not use the vial after this period. It is recommended to note the date of the first use of the vial on the label.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Insuman Basal
Appearance of the Product and Package Size
After mixing, Insuman Basal is a uniform, milky liquid (injectable suspension), without lumps, particles, or visible flocculation.
Insuman Basal is presented in vials containing 10 ml of suspension (400 IU). It is presented in packages of 1 and 5 vials of 10 ml. Only some package sizes may be marketed.
Sanofi-Aventis Deutschland GmbH
D‑65926 Frankfurt am Main
Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder.
België/Belgique/Belgien Sanofi Belgium Tél/Tel: +32 (0)2 710 54 00 | Luxembourg/Luxemburg Sanofi Belgium Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien) |
България SANOFI BULGARIA EOOD Тел.: +359 (0)2 970 53 00 | Magyarország SANOFI-AVENTIS Zrt. Tel.: +36 1 505 0050 |
Česká republika sanofi-aventis, s.r.o. Tel: +420 233 086 111 | Malta Sanofi S.r.l. Tel: +39 02 39394275 |
Danmark Sanofi A/S Tlf: +45 45 16 70 00 | Nederland Genzyme Europe B.V. Tel: +31 20 245 4000 |
Deutschland Sanofi-Aventis Deutschland GmbH Tel: 0800 52 52 010 Tel. from abroad: +49 69 305 21 131 | Norge sanofi-aventis Norge AS Tlf: +47 67 10 71 00 |
Eesti sanofi-aventis Estonia OÜ Tel: +372 627 34 88 | Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0 |
Ελλάδα sanofi-aventis AEBE Τηλ: +30 210 900 16 00 | Polska sanofi-aventis Sp. z o.o. Tel.: +48 22 280 00 00 |
España sanofi-aventis, S.A. Tel: +34 93 485 94 00 | Portugal Sanofi - Produtos Farmacêuticos, Lda Tel: +351 21 35 89 400 |
France sanofi-aventis France Tél: 0 800 222 555 Appel depuis l’étranger : +33 1 57 63 23 23 Hrvatska sanofi-aventis Croatia d.o.o. Tel: +385 1 600 34 00 | România sanofi-aventis România S.R.L. Tel: +40 (0) 21 317 31 36 |
Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 00 | Slovenija sanofi-aventis d.o.o. Tel: +386 1 560 48 00 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika sanofi-aventis Slovakia s.r.o. Tel: +421 2 33 100 100 |
Italia Sanofi S.r.l. Tel: 800 13 12 12 (technical questions) 800 536389 (other questions) | Suomi/Finland sanofi-aventis Oy Puh/Tel: +358 (0) 201 200 300 |
Κύπρος sanofi-aventis Cyprus Ltd. Τηλ: +357 22 871600 | Sverige sanofi-aventis AB Tel: +46 (0)8 634 50 00 |
Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51 | United Kingdom Sanofi Tel: +44 (0) 1483 505 515 |
Lietuva UAB “SANOFI-AVENTIS LIETUVA” Tel: +370 5 2755224 |
Date of the last revision of this prospectus:
Other sources of information
Detailed information about this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/
HYPERGLYCEMIA AND HYPOGLYCEMIA
Always carry some information that indicates you are diabetic
HYPERGLYCEMIA (high blood sugar levels)
If you have very high blood sugar levels (hyperglycemia),you may not have injected enough insulin.
Why do you get hyperglycemia?
Some examples are:
Warning symptoms of hyperglycemia
Thirst, increased need to urinate, fatigue, dry skin, redness of the face, loss of appetite, low blood pressure, rapid heartbeat, and the presence of glucose and ketone bodies in the urine. Stomach pain, deep and rapid breathing, drowsiness, or even loss of consciousness can be signs of a severe condition (ketoacidosis) due to lack of insulin.
What should you do if you suffer from hyperglycemia?
You should analyze your blood sugar level and your acetone level in the urine as soon as you experience any of these symptoms.Hyperglycemia or severe ketoacidosis should always be treated by a doctor, usually in a hospital.
HYPOGLYCEMIA (low blood sugar levels)
If your blood sugar level drops too low, you may lose consciousness. Severe hypoglycemia can cause a heart attack or brain damage and can be life-threatening. You should usually be able to recognize when your blood sugar level is dropping too low to take the necessary measures.
Why do you get hypoglycemia?
Some examples are:
It is also more likely to occur hypoglycemia if:
Warning symptoms of hypoglycemia
Examples of symptoms that indicate your blood sugar level is dropping too low or too quickly: sweating, moist and sticky skin, anxiety, rapid heartbeat, high blood pressure, palpitations, and irregular heartbeat. These symptoms often occur before the symptoms of low blood sugar in the brain appear.
Examples of symptoms that indicate low blood sugar in the brain: headaches, intense hunger, nausea, vomiting, fatigue, drowsiness, sleep disorders, restlessness, aggressive behavior, concentration problems, altered reactions, depression, confusion, speech disorders (sometimes, complete loss of speech), visual disturbances, tremors, paralysis, tingling sensations (paresthesias), numbness and tingling sensations in the mouth area, dizziness, loss of self-control, feeling of helplessness, seizures, loss of consciousness.
The first warning symptoms of hypoglycemia ("warning symptoms") may change, weaken, or be absent if
In this case, you may experience severe hypoglycemia (and even lose consciousness) before you realize the problem. Always be familiar with your warning symptoms. If necessary, more frequent blood sugar analysis can help identify mild hypoglycemic episodes that would otherwise go unnoticed. If you are not sure you can recognize your warning symptoms, avoid situations (such as driving a car) that could put you or others in danger due to hypoglycemia.
What should you do if you suffer from hypoglycemia?
Tell your family, friends, or people close to you:
If you are unable to swallow or lose consciousness, you will need an injection of glucose or glucagon (a medication that increases blood sugar levels). These injections are justified even if you are not sure you have hypoglycemia.
It is recommended to analyze your blood sugar level immediately after ingesting glucose to confirm that you actually have hypoglycemia.